Clinical Trials Directory

Trials / Completed

CompletedNCT05242887

Validation of the 3D-CAM and the UB-CAM in French

Validation of the 3-Minute Diagnostic Interview for CAM-defined Delirium (3D-CAM) and the Ultra-Brief CAM (UB-CAM) in French.

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Delirium is very common in hospitalized older patients and associated with serious clinical bad outcomes (e.g. increased risk of functional decline and death). Despite its high prevalence in the hospital setting, delirium remains underdiagnosed. A better identification would allow an early management and a reduction of its complications. The validation of easy-to-use and quick and formalized tools for the identification of delirium and their implementation in the clinical practice are necessary. Recently, the 3D-CAM (3-minutes Diagnostic interview for Confusion Assessment Method -defined delirium) and the UB-CAM (Ultra-Brief CAM) showed very high sensitivity and specificity (\> 90%), compared to the reference standard (Diagnostic and Statistical Manual of Mental Disorders (DSM criteria)) for the diagnosis of delirium. The investigators aimed to evaluate the sensitivity and specificity of the French versions of the 3D-CAM and the UB-CAM used in delirium screening in older adults hospitalized in geriatric units, compared to reference standard.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDelirium screening using 3D-CAM and UB-CAMPatients will be evaluated with 3D-CAM and UB-CAM by a trained examiner (geriatrician, resident or neuropsychologist). On the same day, they will be given a reference diagnosis of delirium based on DSM-V criteria by another trained examiner, blind to the results of the UB-CAM and 3D-CAM.

Timeline

Start date
2022-03-31
Primary completion
2024-03-27
Completion
2024-03-27
First posted
2022-02-16
Last updated
2024-04-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05242887. Inclusion in this directory is not an endorsement.